Fig. 15
From: Synthetic carbohydrate-based vaccines: challenges and opportunities
TACA modification vaccines (a) propionamide modified GM3-KLH; (b) N-fluoroacetyl modified STn-KLH; (c) N-fluoroacetyl modified TF-CRM197; (d) azido modified Globo H-CRM197
